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Background. Congenital cytomegalovirus (CMV) infection can cause severe birth defects. The majority of children with con-
genital CMV are born to CMV-seropositive women; however, transmission frommother to fetus and resulting defects are more likely
to occur when mothers experience seroconversion during pregnancy. The objective of this study was to provide a population-based
estimate of CMV seropositivity and to identify factors that correlate with the detection of CMV-immunoglobulin (Ig)G antibodies.
Methods. Cytomegalovirus-specific IgG antibodies were determined by enzyme-linked immunosorbent assay in 13 876 serum
samples from children and adolescents (aged 1–17 years). Cytomegalovirus seroprevalence was correlated with children’s age, gen-
der, migration background, country of origin, place of birth, socioeconomic status, breast feeding, daycare attendance, order and
number of siblings, and residence in East versus West Germany.
Results. Age-adjusted seroprevalence was 27.4% (95% confidence interval, 25.8–29.0). Cytomegalovirus seroprevalence in-
creased with age (21.5% at ages 1–2; 32.0% at ages 14–17). Cytomegalovirus seropositivity was significantly associated with migration
background, country of origin and place of birth, and (among migrants only) with low socioeconomic status. Risk factors for CMV
acquisition included the birth order of siblings, breastfeeding, early daycare attendance, and living in East Germany.
Conclusions. In Germany, CMV seroprevalence increases with age, irrespective of gender. These data highlight risk factors
associated with seroprevalence and help to identify a target age for the application of a CMV vaccine.
Keywords. children and adolescents; cytomegalovirus; risk factors; seroprevalence; transmission.
Cytomegalovirus (CMV), a member of the Herpesviridae, can
cause life-threatening disease in immunocompromised individ-
uals as well as in fetuses [1]. The highest risk of transmission
and fetal infection occurs if a seronegative mother acquires
CMV during pregnancy. This intrauterine transmission can re-
sult in microcephaly, mental retardation, developmental delay,
visual impairment/retinitis, convulsions, and frequently hearing
loss [2]. For Germany, an annual number of 3500 congenitally
CMV-infected infants has been estimated [3]. After birth, CMV
is transferred from mother to child by breast feeding [4, 5], and
CMV immunoglobulin (Ig)G seroprevalence increases with age
as children enter daycare facilities. Seropositive children can
shed the virus for months and represent a source of infection
for seronegative children and caregivers [6–9].
During 2003–2006, the Robert Koch Institute conducted the
German Health Interview and Examination Survey for Children
and Adolescents (KiGGS) [10]. This nationally representative
population-based survey collected data from 16 706 individuals
aged 1–17 years. A total of 13 876 sera were tested for CMV IgG
antibodies to obtain an estimate of CMV IgG seroprevalence in
children and adolescents in Germany. We analyzed the associ-
ation between CMV seroprevalence and potential factors influ-
encing infection such as household members including siblings,
breast feeding, and daycare attendance to identify (1) factors/
sources of infection before, during, and after puberty and
(2) risk factors for virus transmission that might result in con-
genital infection.
METHODS
Survey Sample and Design
The KiGGS study is a cross-sectional national health survey
among children and adolescents aged 1–17 years living in
Germany, conducted by the Robert Koch Institute [10]. Children
and adolescents were recruited in 167 sample points (commu-
nities) throughout Germany, stratified by federal state and
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community type. Special care was taken to include children and
adolescents with a migration background. The overall response
rate was 66.6%. Blood samples were collected starting at age
1. The study was approved by the Charité-Universitätsmedizin
Berlin ethics committee and the Federal Office for Data
Protection.
Serological Testing
Serological testing of CMV IgG in patient samples was perfor-
med in the German reference laboratory for measles, mumps,
and rubella at the Robert Koch Institute. Cytomegalovirus
IgG was evaluated in study subjects older than 1 year to rule
out measurement of maternal antibodies.
Cytomegalovirus IgG titer of all serum samples was deter-
mined by the Euroimmune anti-CMV-virus-AT-enzyme-linked
immunosorbent assay (ELISA) (IgG) (Euroimmun, Luebeck,
Germany) based upon lysates from CMV-infected cells. An au-
tomated processor (Tecan Evolyzer, Crailsheim, Germany) was
used. All samples were tested with kits of the same lot number.
The result of the ELISA was calculated by correlation to a stan-
dard curve and expressed in relative units (RU)/mL. This result
was interpreted according to the manufacturer’s recommenda-
tions as negative for titers <16 RU/mL, equivocal for titers ≥16
and <22 RU/mL, and positive for titers ≥22 RU/mL.
Variables
Information was collected in self-administered questionnaires
filled in by the parents and by the adolescents themselves (start-
ing at age 11). A participant was defined to have a 1-sided/
2-sided migration background (MigB) if 1/both of the parents
were not born in Germany and/or had no German citizenship
[11]. For the present analysis, country of origin was defined to
be the country where the mother was born; if this information
was missing or the 1-sided MigB was from the father’s side, the
father’s country of birth was used. The country of origin was
grouped as follows: Turkey; Russian Federation/former Soviet
Union (eg, Lithuania, Ukraine, Belarus, Kasachstan); Central/
Southern Europe (eg, Bosnia, Bulgaria, Greece, Spain, Roma-
nia); Western Europe etc (eg, Belgium, Denmark, France, Slova-
kia, Switzerland, Hungary, Canada, Unites States of America,
Australia); Poland; Arabic-Islamic countries (eg, Lebanon,
Marocco, Pakistan, Senegal, Guinea); other countries (eg,
Argentina, Brazil, Vietnam, the Philippines, China, Angola,
Eritrea) [12]. In the descriptive analyses, nonmigrants and
migrants with a 1-sided MigB were grouped together. The
place of birth of the children themselves was taken from the ad-
olescents’ questionnaire and classified as Germany yes/no. Chil-
dren aged 1–10 were assumed to have been born in Germany if
the year when the mother migrated to Germany was before the
child’s birth year, which introduces some uncertainties in very
young children. Socioeconomic status (SES) was defined based
on the parents’ highest educational status, the parents’ highest
professional status, and household income, and classified into 3
categories [10, 13].Region was categorized as East Germany (in-
cluding Berlin) versus West Germany. Sibling order was defined
based on siblings living in the same household because this pro-
vided somewhat larger associations in preliminary analyses than
using the order of biological siblings. Children and adolescents
were classified as (1) having no siblings or being a middle child
(ie, having both younger and older siblings living in the house-
hold), (2) being the oldest child, or (3) being the youngest child
in the household. Daycare attendance was categorized based
on the age when daycare attendance started (0 or 1 years vs 2
years vs 3 years or older). Breastfeeding was classified as never
breastfed versus ever, but not fully breastfed versus ever breast-
fed with missing information on whether this was full breast-
feeding or not versus fully breastfed, but not until the 4th
month versus fully breastfed until the 4th month or longer.
“Full breastfeeding” means exclusive or predominant breast-
feeding, ie, breastfeeding with possible additional intake of
water or tea [14].
Statistical Analysis
All analyses were done using the KiGGS sampling weights for
the population with a blood sample available. This weight ac-
counted for the unequal sampling probabilities due to the de-
sign and included an adjustment to the German population
statistics (as of December 31, 2004) by age, sex, region, and na-
tionality (German vs non-German) [10]. In sensitivity analyses,
an extended weighting factor was used that additionally adjust-
ed for parental education ×MigB. Standard errors were calcu-
lated by Taylor linearization and taking the weighting and the
clustering in sample points into account, using the survey pro-
cedures in SAS version 12.3 (2012; SAS Institute, Cary, NC).
Confidence intervals (CIs) were calculated on the logit scale.
A multivariable logistic regression model was built to analyze
the association of various factors with CMV IgG seropositivity.
Only participants with complete information on all model var-
iables were included in the model. The final model included sex,
age group, region, MigB, country of origin, place of birth, SES
(low vs medium or high SES), sibling order, daycare attendance,
breastfeeding, and the interaction of MigB and SES. Variable se-
lection was done based on the Akaike information criterion and
the significance level (P = .05). In addition to the adjusted odds
ratios (aOR) and their 95% CIs, predictive margins were calcu-
lated to give an illustration of the aOR on the prevalence scale.
The predictive margins are the averaged probabilities of CMV
IgG seropositivity predicted by the model, comparing, eg,
East and West Germany and leaving all other variables un-
changed [15–17]. Thus, the predictive margins can be thought
of as adjusted prevalences reflecting only the effect of the vari-
able in question, in this case region, assuming that all other var-
iables, eg, MigB, show the same distribution across regions. The
predictive margin for a particular country of origin was calcu-
lated according to the weighted proportion of 1-sided/2-sided
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MigB among all migrants. The predictive margins for 1-sided/
2-sided MigB were calculated once for Turkey, the reference cat-
egory of the country of origin, and once for the marginal distri-
bution of the country of origin among all migrants.
RESULTS
Descriptive Analysis
During 2003–2006, 16 706 individuals aged 1–17 years in
Germany were interviewed for the KiGGS study. Of these,
13 876 (83%) children and adolescents were screened for
CMV IgG antibodies (Table 1).
The overall CMV IgG seroprevalence was 27% (95% CI, 26–
29). There was no significant difference in CMV seroprevalence
between same-aged boys and girls throughout childhood and
teenage years, and seroprevalence increased gradually from in-
fancy to early adulthood (Figure 1). Through all ages, children
and adolescents with a 2-sided MigB had significantly higher
percentages of CMV IgG antibodies than those without MigB,
ranging from 55% in 1- to 2-year-olds to 76% in 14- to 17-
year-olds (Figure 2a). The overall prevalence of CMV IgG was
66% (95% CI, 64−69) in individuals with a 2-sided MigB; in
contrast, only 19% (95% CI, 18−21) of those without a MigB
or with a 1-sided MigB were CMV IgG-positive. A higher prev-
alence of CMV IgG in children born outside Germany (78%; 95%
CI, 74−81) compared with those born in Germany (24%; 95%
CI, 23−26) (Figure 2b) was observed. Apart from the youngest
age group, where the place of birth could not be ascertained
precisely, the increase in CMV IgG seropositivity with age was
less pronounced when stratifying on place of birth than when
stratifying on MigB. The association of CMV IgG seropositivity
with SES differed according to MigB. Migrants with low SES had
statistically significantly higher CMV antibody frequencies com-
pared with those with middle or high SES. Nonmigrants or those
with a 1-sided MigB with a low SES had lower CMV antibody
frequencies than those with middle or high SES (Figure 2c).
Overall, CMV IgG seroprevalence was higher among those
with a low SES (34%; 95% CI, 32−37) than among those with
a middle or high SES (25% and 23%; 95% CI, 23−26 and 21
−25) (Figure 2c). Cytomegalovirus IgG seroprevalence changed
by at most 2 percentage points when the extended weighting fac-
tor was used (results not shown), with the exception of the 1- to
2-year-olds born outside Germany where the prevalence rose
from 46% to 53% with the extended weighting factor.
To identify factors associated with CMV seroprevalence, we
analyzed different variables in a multivariable logistic regression
model that was additionally adjusted for age group (P < .01) and
sex (P = .14) (Table 2). The risk of being CMV seropositive was
higher in East Germany (including Berlin) than in West Ger-
many (aOR = 1.38; 95% CI, 1.18–1.63), corresponding to a dif-
ference in the average predicted probability of being CMV
seropositive of 29% versus 24%.
The odds ratio (OR) for MigB differed by SES (P for interac-
tion = .02). In case of a low SES, the aOR for a 1-sided MigB
versus none was 7.95 (95% CI, 5.09–12.4), and the aOR for a
2-sided MigB versus none was 23.9 (95% CI, 17.4−32.8); in case
of a middle or high SES, the aOR was lower at 7.22 (95% CI, 4.85
−10.7) for a 1-sided and 16.0 (95% CI, 11.3−22.7) for a 2-sided
MigB. It should be noted that these OR refer to Turkey as the
country of origin, the country with the highest aOR. For other
countries of origin, the aOR must be multiplied by the aOR for
the respective country; for example, for children and adoles-
cents with a middle or high SES and a 1-sided MigB from Po-
land, the aOR compared with nonmigrants is 7.22 × 0.20 = 1.46.
Table 1. Study Population and CMV IgG Seroprevalence in 1- to 17-Year-
Olds by Age Group and Sex, KiGGS Study, Germany 2003–2006










1–2 yrs Boys 936 535 57% 21.4% (17.5–25.9)
1–2 yrs Girls 934 523 56% 21.7% (17.5–26.5)
1–2 yrs Total 1870 1058 57% 21.5% (18.4–25.1)
3–6 yrs Boys 1950 1486 76% 24.6% (21.9–27.4)
3–6 yrs Girls 1925 1406 73% 24.6% (21.7–27.7)
3–6 yrs Total 3875 2892 75% 24.6% (22.3–27.0)
7–10 yrs Boys 2127 1860 87% 25.8% (23.5–28.3)
7–10 yrs Girls 2021 1739 86% 25.8% (23.1–28.7)
7–10 yrs Total 4148 3599 87% 25.8% (23.9–27.8)
11–13 yrs Boys 1588 1467 92% 28.0% (24.9–31.2)
11–13 yrs Girls 1488 1382 93% 29.1% (26.3–32.2)
11–13 yrs Total 3076 2849 93% 28.5% (26.1–31.1)
14–17 yrs Boys 1904 1775 93% 30.5% (27.9–33.4)
14–17 yrs Girls 1833 1703 93% 33.5% (30.8–36.3)
14–17 yrs Total 3737 3478 93% 32.0% (29.9–34.1)
Total Boys 8505 7123 84% 26.8% (25.1–28.6)
Total Girls 8201 6753 82% 27.9% (26.1–29.8)
Total Total 16 706 13 876 83% 27.4% (25.8–29.0)
Abbreviations: CI, confidence interval; CMV, cytomegalovirus; Ig, immunoglobulin; KiGGS,
German Health Interview and Examination Survey for Children and Adolescents.
Figure 1. CMV seroprevalence (in percent) in children and adolescents in
Germany, by age group and sex (boys left, girls right). In addition, total seropreva-
lence is shown.
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The predictive margins were highest for Turkey (70%), Russia
and the former Soviet Union (63%), and Arabic-Islamic coun-
tries (58%) and lowest for Poland (36%) and Western Europe,
North America, etc (21%). For all countries of origin taken to-
gether, the predictive margins were 39% for a 1-sided and 61%
for a 2-sided MigB, respectively, versus 17% for nonmigrants in
case of a low SES. In case of a middle or high SES, the predictive
margins were 39% for a 1-sided and 55% for a 2-sided MigB,
versus 19% for nonmigrants. The risk for CMV seropositivity
was further increased when a child was born outside Germany
(aOR = 2.11; 95% CI, 1.51–2.94), corresponding to a predictive
margin of 38% (vs 25% for children born in Germany).
An association of SES and CMV seropositivity was only found
among children and adolescents with a 2-sided MigB (P for in-
teraction = .02), where the aOR for a low SES was 1.35 (95% CI,
1.05–1.73) compared with migrants with a middle or high SES,
with predictive margins of 61% and 55%, respectively.
First-born children and adolescents had a higher risk of being
CMV seropositive (aOR = 1.36; 95% CI, 1.20–1.54; predictive
margin 30%) compared with “middle children” or children and
adolescents without siblings (predictive margin 25%). Youngest
children, on the other hand, had a lower risk (aOR = 0.77; 95%
CI, 0.68–0.86; predictive margin 21%) than those without sib-
lings. When the number of siblings was added to the model,
the risk increased by aOR = 1.08 per sibling (P = .06), but the pro-
tective effect for the youngest child remained unless the number
of siblings was 3 or more where the risk was similar to children
without siblings (results not shown).
Children enrolled in daycare before the age of 2 had a higher
risk for CMV seropositivity with an aOR of 1.35 (95% CI, 1.15–
1.59; predictive margin 29%) compared with children who were
at home or only attended daycare at 3 years or later (predictive
margin 24%). A nonsignificantly elevated aOR of 1.15 (95% CI,
0.95–1.39; predictive margin 26%) was observed when daycare
started at age 2.
Finally, breastfeeding increased the risk of being CMV sero-
positive, with the OR compared with children never breastfed
(predictive margin 16%) increasing with the extent and dura-
tion of breastfeeding. For children not fully breastfed, the aOR
was 1.38 (95% CI, 1.11–1.72; predictive margin 20%), and it in-
creased to aOR = 2.77 (95% CI, 2.35–3.26) and a predictive mar-
gin of 30% in children fully breastfed until the 4th month or
longer. Sensitivity analyses revealed a further increase in risk
when breastfeeding continued until the 6th month or longer
(aOR = 2.95 compared with aOR = 2.57 for breastfeeding until
the 4th or 5th month). Sensitivity analyses with the extended
weighting factor or including missing covariate values as valid
values in the model did not change the results appreciably.
DISCUSSION
In our study population of 13 876 children and adolescents,
CMV IgG seroprevalence ranged between 21.4% (boys at 1–2
years of age) and 33.5% (girls at 14–17 years of age) with an
overall seroprevalence of 27%. For children 1–5 years of age,
we detected CMV IgG seroprevalence between 21% and 25%.
These results are comparable with data obtained from similar
age groups from the National Health and Nutrition Examination
Survey (NHANES) of 2011–2012 in the United States (CMV IgG
seroprevalence of 20.7%); however, for 1-year-olds, 12.3% was re-
ported for the United States compared with 22% in Germany
[18]. Our numbers are higher than those reported for the same
age group from a single center 30 years ago [8]. In Germany,
Figure 2. Variables associated with CMV seroprevalence (in percent). For all age
groups, CMV seroprevalence is higher in children and adolescents with migration
background (A) and if the place of birth was outside Germany (B). In migrants,
CMV seroprevalence increases with lower socioeconomic status (SES), which is
not observed in non-migrants (C).
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Table 2. Results of Multivariable Logistic Regression Model for CMV IgG Seropositivity in 1- to 17-Year-Olds, KiGGS Study, Germany 2003–2006










aORa (95% CI) Predictive
Margin
Region East Germany (including Berlin) 5569 4714 85% 4221 76% <.01 <.01 1.38 (1.18–1.63) 29%
West Germany 11 137 9162 82% 8011 72% Ref. 24%
MigB, stratified by SESb Nonmigrant, low SES 2984 2410 81% 2179 73% <.01 Ref. 17%
1-sided MigB, low SES 327 255 78% 203 62% <.01 7.95c (5.09–12.4) 59%/39% d
2-sided MigB, low SES 1193 950 80% 668 56% <.01 23.9c (17.4–32.8) 80%/61%d
Nonmigrant, middle/high SES 9865 8370 85% 7935 80% Ref. 19%
1-sided MigB, middle/high SES 868 695 80% 594 68% <.01 7.22c (4.85–10.7) 60%/39%d
2-sided MigB, middle/high SES 1013 831 82% 653 64% <.01 16.0c (11.3–22.7) 76%/55%d
MigB and/or SES missing 456 365 80% 0
Country of origin Turkey 765 591 77% 411 54% <.01 Ref. 70%
Russian Fed., former SU 651 538 83% 395 61% .10 0.70 (0.46–1.07) 63%
Central/Southern Europe 631 513 81% 387 61% <.01 0.28 (0.19–0.41) 43%
Western Europe, USA etc 383 322 84% 307 80% <.01 0.09 (0.05–0.15) 21%
Poland 364 315 87% 269 74% <.01 0.20 (0.13–0.30) 36%
Arabic-Islamic 295 230 78% 163 55% <.01 0.55 (0.38–0.79) 58%
Other 324 252 78% 186 57% <.01 0.45 (0.28–0.71) 54%
Missing 481 354 74% 0
Place of birth Other country 778 680 87% 431 55% <.01 <.01 2.14 (1.54–2.96) 38%
Germany 15 776 13 085 83% 11 801 75% Ref. 25%
Missing 152 111 73% 0
SES, stratified by MigBb Low SES, nonmigrant 2984 2410 81% 2179 73% .06 .20 0.90 (0.78–1.05) 17%
Middle/high SES, nonmigrant 9865 8370 85% 7935 80% Ref. 19%
Low SES, 1-sided MigB 327 255 78% 203 62% .98 1.00 (0.64–1.55) 39%e
Middle/high SES, 1-sided MigB 868 695 80% 594 68% Ref. 39%e
Low SES, 2-sided MigB 1193 950 80% 668 56% .02 1.35 (1.05–1.73) 61%e
Middle/high SES, 2-sided MigB 1013 831 82% 653 64% Ref. 55%e
SES and/or MigB missing 456 365 80% 0
Sibling order Middle child/no siblings 5404 4474 83% 4149 77% <.01 Ref. 25%
Oldest child 4357 3727 86% 3503 80% <.01 1.36 (1.20–1.54) 30%
Youngest child 5978 4902 82% 4580 77% <.01 0.77 (0.68–0.86) 21%
Missing 967 773 80% 0
Daycare Daycare started at age 0 or 1 yrs 2942 2424 82% 2286 78% <.01 <.01 1.35 (1.15–1.59) 29%
Daycare started at age 2 yrs 2076 1782 86% 1675 81% .16 1.15 (0.95–1.39) 26%
No daycare before age 3 10 702 8903 83% 8271 77% Ref. 24%
















CMV seroprevalence among adolescent females and males aged
11–17 years ranged between 29% and 33% and 28% and 31%, re-
spectively, and are lower than those found in smaller cohorts
from the United States [19, 20]. Because this survey was conduct-
ed among children and adolescents, no data on maternal CMV
serostatus are available, although variations in maternal serosta-
tus are likely to contribute to differences in our subgroups.
Consistent with earlier published NHANES data [21], we
found increased CMV IgG seroprevalence in older children, in
those with MigB, birth outside Germany, and lower SES. An
age-dependent increase in seroprevalence has been documented
in several studies [21–27]; however, a study from Norway report-
ed a high regional CMV seroprevalence in young pregnant
women [28]. Data from 40 324 pregnant women in Germany
showed that seroprevalence of CMV IgG was 42.3% and higher
among young women [29]. This might be attributed to increased
attendance of daycare facilities and higher rates of breastfeeding
but also to different demographics of young pregnant women be-
cause unmarried women and women with lower SES or foreign
nationality are overrepresented in this group. In a group of 24 260
healthy blood donors in Germany, CMV seroprevalence was re-
ported to be higher in female blood donors with a highest rate of
CMV seroconversion in those donors between 30 and 35 years of
age [30]. Although these data might not be representative, ap-
proximately 30% of live births in Germany are born to women
between 30 and 35 years of age, which represents the group
with a higher seroconversion rate according to the data from
Hecker et al [30], and these women are exposed to their young
children. The relatively low level of maternal CMV seropreva-
lence in Germany is likely to contribute to a lower overall sero-
prevalence, especially on our cohort of children and adolescents.
In our study, daycare attendance starting before the age of
3 increased the risk of CMV seropositivity. Although this has
been reported previously [31, 32], little association between day-
care attendance and CMV seroprevalence has been documented
by other groups [6, 33–35]. This might be due to the amount of
time children spend in the facility at young age but might be
influenced by ethnicity and/or household circumstances.
Family members of young children have been reported to be
at high risk for CMV infection [36, 37]. This correlates with our
finding that the oldest child in a family bears the highest risk of
being CMV seropositive and strongly supports that household
transmission influences CMV seroprevalence among preadoles-
cent children. Likewise, breastfeeding increased the risk of
CMV seropositivity. This is in accordance with data from
non-Hispanic white children and Mexican American children
with foreign-born parents in the United States [6]. Breastfeeding
rates vary by ethnicity and MigB; for example, mothers from
Eastern Europe tend to breastfeed their children more frequently
and over longer time periods.
In previous studies, African American women caring for
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being at risk for virus transmission that might result in con-
genital infection [19]. In our study, children with a 2-sided
MigB or those who were born outside Germany had a higher
CMV IgG seroprevalence; however, this subgroup represents
only a relatively small proportion of the population (approxi-
mately 1 in 6 children have a 2-sided MigB). In studies compar-
ing United States-born to non-United States-born children,
CMV seroprevalence was shown to be higher in groups with
MigB [21]. Immunoglobulin G seroprevalence was only associ-
ated with lower SES in children and adolescents with a 2-sided
MigB in our cohort. This may be due to the fact that income is
more equally distributed in Germany than in other countries,
such as Brazil or the United States, so that living conditions
are not so disparate among the native German population
[38]. On the other hand, this may also reflect the substantial
heterogeneity that is present within the migrant population.
The major strength of this study is that it provides nationally
representative information on age-specific CMV seropreva-
lence and determines associated demographic factors. Due to
its cross-sectional design, our study cannot clarify the actual
onset of CMV infection and only examines variables that were
documented at the time of study. Cytomegalovirus seropreva-
lence in children could not be correlated with the maternal se-
rostatus, and we cannot provide data to identify age groups
bearing a higher potential to serve as a source of infection.
An evaluation regarding a possible correlation between onset
of sexual activity and CMV serostatus is currently under inves-
tigation, evaluating whether exposure to young children results
more easily in CMV infection than sexual behavior in adoles-
cents, as stated previously [19].
CONCLUSIONS
In conclusion, our data provide important information on
CMV seroprevalence in children and adolescents in Germany
that might help to assess optimal age for CMV vaccination in a
populationwith overall lowCMVseroprevalence. Because young
women in their reproductive years are more likely to become
infected for the first time and thus are at particular risk of pass-
ing the virus to their fetus, they might be considered for inter-
ventional studies including vaccine trials. Therefore, these data
might be useful on a regional level. However, the rate of CMV
seroprevalence varies widely by country or even region, and in
countries like Brazil where CMV seroprevalence is already high
at young age [39], the data may not be helpful to identify the
best target group for vaccination. To determine the latter, indi-
vidual assessments are necessary.
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